Biz Blog

Choose a blog

GSK joins global effort to fight tropical diseases

Bookmark and Share

GlaxoSmithKline has joined an international effort to help eliminate sleeping sickness, leprosy, elephantiasis, blind trachoma and guinea worm in developing countries.

Those diseases and five others have been designated as neglected tropical diseases by the World Health Organization. The international group says they affect more than 1 billion people and have targeted them for elimination or control.

GSK, which has its U.S. headquarters in Research Triangle Park, said today it will expand its donation of albendazole, to supply all that is needed to eliminate  elephantiasis by 2020.  Since 2000, it has already donated 2.6 billion tablets in 58 countries.

Elephantiasis causes a thickening of skin and swelling in the lower torso, typically legs and genitals, and is caused by parasitic worms. GSK's tablets are used to de-worm school children.

GSK is also sharing its research  with not-for-profit initiatives that are trying to develop drugs to combat other neglected tropical diseases.

GSK is now part of a global partnership that includes the World Health Organization, the Bill & Melinda Gates Foundation, the UK Department for International Development and the U.S. Agency for International Development.

In announcing GSK's participation, CEO Andrew Witty said in a statement:  “We fully support the WHO’s bold vision and we are committed to playing our part in helping to achieve universal coverage of intervention programmes for diseases that can be controlled or eliminated by existing treatments, and to spur R&D into new treatments for diseases where none currently exist. Through this new partnership, we have both the means and the energy to strike a decisive blow against disease in the world’s poorest countries.”

Cars View All
Find a Car
Jobs View All
Find a Job
Homes View All
Find a Home

Want to post a comment?

In order to join the conversation, you must be a member of Click here to register or to log in.

About the blogger

Mary Cornatzer has worked at The News & Observer for more than 25 years, covering the local music industry, state movie industry and travel. She has been the paper's Business editor since 2000. Contact Mary at 919-829-4755 or e-mail her.